Huntington Disease and Chorea

Area of Science:

• Neurology
• Genetics
• Movement Disorders

Background:

• Chorea is a hyperkinetic movement disorder with diverse causes in children and adults.
• Huntington disease (HD) is a primary focus for understanding choreiform disorders.
• Diagnostic criteria for HD are evolving with genetic testing and imaging biomarkers.

Purpose of the Study:

• To present a systematic approach to diagnosing and managing choreiform disorders.
• To highlight Huntington disease as a model for these conditions.
• To review the identification, diagnosis, and treatment of chorea.

Main Methods:

• Review of current literature on choreiform disorders and Huntington disease.
• Discussion of diagnostic approaches, including genetic and acquired forms.
• Examination of emerging therapeutic strategies for chorea and HD.

Main Results:

• Genetic testing and imaging biomarkers are redefining HD diagnosis.
• Valbenazine is a new treatment option for chorea in HD.
• Disease-modifying strategies targeting huntingtin protein are under development.

Conclusions:

• A comprehensive diagnostic and management strategy is crucial for choreiform disorders.
• Advances in understanding HD pathophysiology are driving new therapeutic developments.
• The landscape of choreiform disorders is complex, requiring a multifaceted approach.